Humanized antibody
Term · Chemistry · MLC-T-CHM-005426
A type of monoclonal antibody engineered to reduce immunogenicity when administered to humans, typically derived from non-human species like mice. This modification involves replacing most of the non-human antibody sequence with human sequences, retaining only the antigen-binding regions (complementarity-determining regions) from the original antibody. These antibodies are widely used in therapeutic applications to treat diseases such as cancer and autoimmune disorders.
| Identifier | MLC-T-CHM-005426 |
|---|---|
| Field | Chemistry |
| Subject | Chemistry and Human Health |
| References | PAC, 2012, 84, 1113. 'IUPAC glossary of terms used in immunotoxicology (IUPAC Recommendations 2012)' on page 1178 (https://doi.org/10.1351/PAC-REC-11-06-03) |
| See also | Complementarity-determining region; Therapeutic antibody |
Record as JSON
{
"id": "MLC-T-CHM-005426",
"term": "Humanized antibody",
"field": "Chemistry",
"definition": "A type of monoclonal antibody engineered to reduce immunogenicity when administered to humans, typically derived from non-human species like mice. This modification involves replacing most of the non-human antibody sequence with human sequences, retaining only the antigen-binding regions (complementarity-determining regions) from the original antibody. These antibodies are widely used in therapeutic applications to treat diseases such as cancer and autoimmune disorders.",
"subject": "Chemistry and Human Health",
"see_also": [
"complementarity-determining region",
"therapeutic antibody"
],
"references": [
"PAC, 2012, 84, 1113. 'IUPAC glossary of terms used in immunotoxicology (IUPAC Recommendations 2012)' on page 1178 (https://doi.org/10.1351/PAC-REC-11-06-03)"
],
"url": "https://mlchart.com/terminology/chemistry/humanized-antibody/"
}
Record 5,748 of 13,676 in Chemistry terminology (MLC-0109). Request the full dataset.